Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 17, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • Pfizer

Tag: Pfizer

  • Cellular Communication
  • DNA-Tales

Angela Hwang: Group President, Pfizer Biopharmaceuticals

BioTech Today December 5, 2021December 5, 2021

Mahek Sharan, Institute of Applied Medicines and Research, Ghaziabad BIOXONE BIOSCIENCES SERIES – “Extraordinary Women in Biosciences”- Day 6 In the field of biosciences, Angela Hwang is a well-known name. She is the group president of leading America-based multinational biopharmaceutical company, Pfizer with a net worth of 1.6 million dollars. Going through her life, clearly shows […]

Read More
  • BiotechToday
  • World

COVID-19 vaccine for children: Pfizer shows progress!

BioTech Today November 22, 2021November 22, 2021 1

Ananya Ghosal, MAKAUT(WB) COVID-19 vaccine is still a dream for children under 12. Although children are not at risk of COVID-19 like adults, their reports are still positive. The delta variant and reopening of schools combined and resulted in a keen rise in pediatric COVID-19 cases that is related to the records in the pandemic. […]

Read More
  • BiotechToday
  • World

Shionogi is in a race against Pfizer and Merck

BioTech Today August 4, 2021August 4, 2021 2

Sneha Singhal, Jaypee Institute of information technology, Noida Pfizer Inc. and Merck & Co. in the race to find treatments for Covid-19 have joined a Japanese company in starting human trials for the first once-daily pill. Shionogi and Co., of Osaka, claimed that its pill would neutralize the Coronavirus in five days or less. The […]

Read More
  • BiotechToday
  • World

High risk of COVID-19 in organ transplant patients

BioTech Today July 29, 2021July 29, 2021

Soumya Shraddhya Paul, Amity University, Noida The extent to which Covid vaccinations can protect people who have organ transplants is yet unknown. Transplantation doctors have long feared that the Covid vaccinations aren’t providing enough protection to patients undergoing transplants. Few studies have suggested that even after being completely vaccinated with mRNA vaccines, which are believed […]

Read More
  • BiotechToday
  • World

J&J COVID-19 vaccine: A potential disaster for humans

bioxone July 14, 2021July 14, 2021 1

Saptaparna Dasgupta, Bennett University The COVID-19 vaccine has been created as an emergency vaccine, based on several strategies, such as mRNA vaccine, inactivated virus vaccine, etc. The other vaccines having cleared the clinical trials have passed on to the mass population vaccination drives, without any reported risk factors, yet. However, Johnson and Johnson’s COVID 19 […]

Read More
  • BiotechToday
  • World

COVID-19 vaccine in Immunocompromised individuals.

bioxone July 10, 2021July 9, 2021 1

Avani Dave, Jai Hind College A recent study conducted by Satveer Mahil et al., showcased in the current year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and published in The Lancet Rheumatology, demonstrates that it is not the response of T-cell but that of the antibody to the first jab of the Pfizer […]

Read More
  • BiotechToday
  • World

Leukocytoclastic vasculitis occurrence after SARS-CoV2 vaccine

bioxone July 4, 2021July 4, 2021

Madhavi Bhatia,NIPER Guwahati SARS-covid-19 is now well-known as a severe acute respiratory syndrome that has affected all parts of the world. It has caused almost 3.9 million deaths worldwide resulting in a global pandemic. To curb the disease, various drugs are approved and used worldwide.  Today, immunization is considered a safe and effective tool to […]

Read More
  • Biotechnopedia
  • DNA-Tales

COVID-19 Vaccines Around The World

bioxone May 17, 2021May 17, 2021 2

Souhrid Sarkar, Amity University Kolkata What is COVID-19? Coronaviruses are a family of viruses that may cause mild to severe respiratory disorders including death. The term ‘Corona’ means crown-like spikes on the surface of the virus. Some of the examples of coronavirus are Severe acute respiratory syndrome (SARS), the Middle East respiratory syndrome (MERS), and […]

Read More
  • BiotechToday
  • World

Vaccination update: Pfizer allowed for emergency use in adolescents

bioxone May 12, 2021May 12, 2021 1

Camelia Bhattacharyya, Amity University Kolkata Amongst all the most awaited news, the updates on vaccination are the ones most wanted these days. People have finally become aware of the need for vaccination, and the number of anti-vaxxers has reduced. This has helped the medical community level up their reviews on saving lives, and information regarding […]

Read More
  • BiotechToday
  • World

Pfizer vaccine- Is it really effective?

bioxone March 26, 2021March 26, 2021

Thota Kanishka Rao, Amity University Kolkata Coronavirus became a household name, as the pandemic swept people off their feet, locking them in their houses, rendering them sick, leading to death on severe occasions. After months into the pandemic, in December 2020, the government of Israel approved the BNT162b2 COVID-19 vaccination and proclaimed a mass immunization […]

Read More

Posts navigation

1 2

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy